Ansa Mc Al should go public with their opinion over Tender Board’s decision on drug contract –Cabinet Secretary

 

Georgetown : Head of the Presidential Secretariat Dr. Roger Luncheon has challenged Ansa Mc Al to go public with their argument about the National Procurement and Tender Administration Board (NPTAB) being biased as it relates to the contract for the supply of drugs to the Ministry of Health.

 Dr. Luncheon was at the time responding to questions at his post- Cabinet media briefing about, Ansa Mc Al responding to the NPTAB about their decision to award the contract  to New GPC Inc.

“I think efforts made to have a view of the tender board and the subsequent Cabinet decision deemed questionable, this is in the public domain, this is a public statement and I essentially offered a suggestion why don’t you follow up in the public domain,”

The Cabinet Secretary said with the substance of Ansa McAl’s submission, if they are of the belief that the tender board and the Cabinet erred in not recognising their bids, then they should make an appeal in the public domain as they did previously.

“Let us hear and see what it was since that we are appealing for public opinion, substantiate in the public domain, someone said they didn’t want to go public.”

President Donald Ramotar had recently confirmed that the contract for the pre-qualification of suppliers for the supply and delivery of pharmaceuticals and other medical supplies and consumerables in the health sector was awarded to the New GPC Inc., after the two other applicants failed to meet the criteria, set out by the evaluation team.

The President said that the decision of awarding the contract was done strictly at the level of the NPTAB and not at the level of Cabinet.

According to the President, the other two applicants who did not meet the criteria for the contracts have the right to appeal the decision.

The International Pharmaceutical Agency (IPA), Ansa McAL, and New GPC were among four other companies that submitted pre-qualification documents for the supply and delivery of medical and pharmaceutical supplies for Guyana’s health sector.

After the contract was awarded to New GPC, the two other companies, in the media have claimed that the contract was awarded to New GPC in spite of the fact that they met the criteria for the contract. The companies also claimed that they were not notified when the award was made.